Christidi, F.; Tsiptsios, D.; Sousanidou, A.; Karamanidis, S.; Kitmeridou, S.; Karatzetzou, S.; Aitsidou, S.; Tsamakis, K.; Psatha, E.A.; Karavasilis, E.;
et al. The Clinical Utility of Leukoaraiosis as a Prognostic Indicator in Ischemic Stroke Patients. Neurol. Int. 2022, 14, 952-980.
https://doi.org/10.3390/neurolint14040076
AMA Style
Christidi F, Tsiptsios D, Sousanidou A, Karamanidis S, Kitmeridou S, Karatzetzou S, Aitsidou S, Tsamakis K, Psatha EA, Karavasilis E,
et al. The Clinical Utility of Leukoaraiosis as a Prognostic Indicator in Ischemic Stroke Patients. Neurology International. 2022; 14(4):952-980.
https://doi.org/10.3390/neurolint14040076
Chicago/Turabian Style
Christidi, Foteini, Dimitrios Tsiptsios, Anastasia Sousanidou, Stefanos Karamanidis, Sofia Kitmeridou, Stella Karatzetzou, Souzana Aitsidou, Konstantinos Tsamakis, Evlampia A. Psatha, Efstratios Karavasilis,
and et al. 2022. "The Clinical Utility of Leukoaraiosis as a Prognostic Indicator in Ischemic Stroke Patients" Neurology International 14, no. 4: 952-980.
https://doi.org/10.3390/neurolint14040076
APA Style
Christidi, F., Tsiptsios, D., Sousanidou, A., Karamanidis, S., Kitmeridou, S., Karatzetzou, S., Aitsidou, S., Tsamakis, K., Psatha, E. A., Karavasilis, E., Kokkotis, C., Aggelousis, N., & Vadikolias, K.
(2022). The Clinical Utility of Leukoaraiosis as a Prognostic Indicator in Ischemic Stroke Patients. Neurology International, 14(4), 952-980.
https://doi.org/10.3390/neurolint14040076
